---
title: "125 Series A Medtech Investors (Nov 2026)"
last_updated: "2026-11-07"
rows: "125"
free_rows: "25"
source: "SEC Form D filings and our own research"
canonical: "https://theinvestordatabase.com/lists/series-a-medtech-investors/"
---

# 125 Series A medtech investors

We list 125 Series A medtech investors as of November 2026: 78 have an SEC filing on file and 47 were checked on the firm's own website or an official register, and the list was last checked on 7 Nov 2026. The states with the most are California (24), New York (8) and Massachusetts (7).

- 125 investors
- 64 with a fund filing or dated deal in the last 12 months
- $88M median fund size on file (SEC Form D, 50 firms)
- 643 named decision-makers on file

## First 25 of 125 Series A medtech investors

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| Mercia Asset Management | Fund manager | Henley-in-Arden, United Kingdom | Seed, Series A, Growth | Medtech, Healthtech, Future of Work, AI | Portfolio news, Oct 2026 | £400M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/mercia/ |
| SHD Partners | VC firm | Dallas, TX | Seed, Series A | Medtech, Healthtech, Biotech | Portfolio news, Nov 2026 | $61M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/shd-partners/ |
| HC9 Ventures | VC firm | Havertown, PA | Seed, Series A | Medtech, Healthtech, AI, Fintech | New fund, Oct 2026 | $85M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/hc9-ventures/ |
| BGF | VC firm | United Kingdom | Seed, Series A, Series B, Growth | Medtech, Healthtech, Edtech, Developer Tools | Portfolio news, Oct 2026 | £3.0B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/bgf/ |
| 25Madison Ventures | VC firm | New York, NY | Pre-seed, Seed, Series A | Medtech, Healthtech, AI, Logistics | New fund, Oct 2026 | $50M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/25madison-ventures/ |
| IW Capital | SEIS/EIS fund | London, United Kingdom | Series A | Medtech, Healthtech, AI, SaaS | New deal, Oct 2026 | £185M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/iw-capital/ |
| Claritas Signal Partners | VC firm | Nashville, TN | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Media | New deal, Aug 2026 | $14M (SEC Form D, 2021) | 2026-11-05 | https://theinvestordatabase.com/investors/claritas-signal-partners/ |
| Parkwalk Advisors | SEIS/EIS fund | London, United Kingdom | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Industrial Tech | New fund, Sep 2026 | £500M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/parkwalk/ |
| Angelor | VC firm | Lyon, France | Seed, Series A | Medtech, Healthtech, Biotech, Food and Beverage | New deal, Sep 2026 | €100M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/angelor/ |
| HBM Partners | Fund manager | Zug, Switzerland | Series A, Series B, Growth, Late stage | Medtech, Healthtech, Biotech | Portfolio news, Oct 2026 | $2.8B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hbm-partners-ag/ |
| Khosla Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed, Series A, Growth | Medtech, AI, Consumer, B2B | New fund, Aug 2026 | $1.9B (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/khosla-ventures/ |
| Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Medtech, Biotech, Healthtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/andera-partners/ |
| FCA Venture Management Group | VC firm | Nashville, TN | Seed, Series A, Series B | Medtech, Healthtech, AI, Biotech | Portfolio news, May 2026 | $58M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/fca-venture-management-group/ |
| Star51 Capital | VC firm | New York, NY | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Robotics | New deal, Sep 2026 |  | 2026-11-04 | https://theinvestordatabase.com/investors/star51-capital/ |
| Felicis | VC firm | Menlo Park, CA | Seed, Series A | Medtech, AI, Developer Tools, Healthtech | New deal, Oct 2026 | $900M (SEC Form D, 2025) | 2026-11-05 | https://theinvestordatabase.com/investors/felicis/ |
| Hadean Ventures | VC firm | Norway | Seed, Series A, Series B | Medtech, Healthtech, Biotech | New deal, Sep 2026 | €230M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hadean-ventures-as/ |
| Sandbox Clinical Ventures | VC firm | Chicago, IL | Seed, Series A, Series B, Growth | Medtech, Insurtech, Healthtech, AI | New fund, Sep 2026 | $100M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/sandbox-clinical-ventures/ |
| 819 Capital Partners | VC firm | Deventer, Netherlands | Seed, Series A, Growth | Medtech, Healthtech, Biotech, Generalist | Portfolio news, Sep 2026 | €100M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/819-capital-partners/ |
| Roo Capital | VC firm | Coconut Grove, FL | Pre-seed, Seed, Series A, Growth | Medtech, AI, Healthtech, Future of Work | New fund, Aug 2026 | $125M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/roo-capital/ |
| Balderton Capital | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Fintech | Portfolio news, Oct 2026 | $5.7B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/balderton-capital/ |
| Cybernetix Ventures | VC firm | Boston, MA | Pre-seed, Seed, Series A | Medtech, Robotics, Industrial Tech, Logistics | New fund, Aug 2026 | $100M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/cybernetix-ventures/ |
| Cultivation Capital | VC firm | St. Louis, MO | Seed, Series A, Series B | Medtech, Healthtech, Biotech, SaaS | New fund, Sep 2026 | $100M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/cultivation-capital/ |
| Healthier Capital | VC firm | Menlo Park, CA | Series A | Medtech, Healthtech, AI, SaaS | New fund, Nov 2025 | $200M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/healthier-capital/ |
| Define Ventures | VC firm | San Francisco, CA | Pre-seed, Seed, Series A, Series B | Medtech, Healthtech, AI, Future of Work | New deal, Apr 2026 | $425M (SEC Form D, 2022) | 2026-11-05 | https://theinvestordatabase.com/investors/define-ventures/ |
| Cornucopian Capital | VC firm | Montclair, NJ | Pre-seed, Seed, Series A, Series B | Medtech, Healthtech, AI, Biotech | New fund, Aug 2026 | $12M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/cornucopian-capital/ |

You are seeing 25 of 125. The full list adds 100 more investors and 643 named decision-makers.

Get all 125 investors and 643 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/series-a-medtech-investors
This page: https://theinvestordatabase.com/lists/series-a-medtech-investors/

## Method and limits
- Source: 78 of the 125 rows carry an SEC filing (Form D or Form ADV). All 125 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states medtech and medical devices as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at Series A.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when Series A is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 125 rows: stage 125, sector 125, fund size 93, website 125. In the paid file: named decision-makers on 117 rows, firm email on 66, LinkedIn page on 88, check size on 33.

## Questions
### How many Series A medtech investors are there?
We list 125 as of November 2026. 64 of the 125 have a fund filing or a dated deal in the last 12 months.

### Which Series A medtech investors raised a new fund in the last 12 months?
24 of the 125 have a fund filing dated in the last 12 months. The most recent on this list are 25Madison Ventures (Oct 2026), Switchboard (Oct 2026) and HC9 Ventures (Oct 2026).

### What is the typical fund size of Series A medtech investors?
The median fund size on file for this list is $88M, across the 50 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 75 do not disclose a size there.

### How do I contact Series A medtech investors?
The paid file holds 643 named decision-makers across 117 of these 125 and a firm email for 66. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.

### Where does the data on Series A medtech investors come from?
78 of the 125 rows have an SEC filing on file (Form D or Form ADV) and 47 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 7 Nov 2026 at the latest. The whole file is re-verified twice a year.